CXCR4 and hepatocellular carcinoma: Given that CXCR4 has been linked with the metastasis, and poor survival in HCC [8], CXCR4 can be considered as an ideal molecular target for the investigation of novel therapeutic interventions for the prevention and treatment of metastatic HCC.